Methods of enhancing bioavailability of drugs

35,200 views 36 slides Apr 11, 2019
Slide 1
Slide 1 of 36
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36

About This Presentation

For pharma students


Slide Content

Methods of Enhancing Bioavailability Of Drugs Presented By-Debasish Ghadei M.B.A. (Pharmaceutical Management) (2 nd Sem ) Roll No-21142 1

Contents: Introduction to Bioavailability Enhancement of Bioavailability Approaches used in overcoming Bioavailability Problems Methods of Enhancing Bioavailability 2

Bioavailability It is defined as the rate and extent amount of absorption of unchanged drug from dosage form. 3

Enhancement of Bioavailability As far as the bioavailability is concerned, a drug with poor bioavailability is the one with : Poor aqueous solubility or slow dissolution rate in biological fluid. Poor permeability through the bio membrane owing to inadequate partition coefficient or lipophilicity or large molecular size such as that of protein or peptide drug like insulin. 4

Biopaharmaceutics classification system (BCS) 5

Approaches used in overcoming Bioavailability Problems: The pharmaceutical Approach The pharmacokinetic Approach The biological Approach

Methods of Enhancing Bioavailability ( The pharmaceutical Approach) Enhancement of drug solubility or dissolution rate Enhancement of drug permeability Enhancement of drug stability Enhancement of gastrointestinal retentions. 7

Enhancement of Drug stability or dissolution rate Micronization Nano suspension Supercritical fluid process Spray freezing into liquid(SFL) Evaporate precipitation into aqueous solution(EPAS) Use of surfactant Use of salt forms Use of precipitation inhibitors Alteration of pH of drug microenvironment Use of amorphs,anhydrates,solvetes & metastable polymorphs Solvent deposition Precipitation Selective absorption on insoluble carriers Solid solutions Eutectic mixture Solid dispersions Molecular encapsulation with cyclodextrins 8

Enhancement of drug permeability Lipid technologies Ion Pairing Penetration enhancers 9

Enhancement of drug stability Enteric coating Complexation Use of metabolism inhibitors 10

Enhancement of gastrointestinal retention Increased contact with epithelial surface Prolonged residence time in the stomach Delaying intestinal transit 11

Enhancement of Drug stability or dissolution rate Micronization Nano suspension Supercritical fluid process Spray freezing into liquid(SFL) Evaporate precipitation into aqueous solution(EPAS) Use of surfactant Use of salt forms Use of precipitation inhibitors Alteration of pH of drug microenvironment Use of amorphs,anhydrates,solvetes & metastable polymorphs Solvent deposition Precipitation Selective absorption on insoluble carriers Solid solutions Eutectic mixture Solid dispersions Molecular encapsulation with cyclodextrins 12

13

14

15

16

17

18

19

20

21

22

23

24

25

26 Enhancement of drug permeability Lipid technologies Ion Pairing Penetration enhancers

27

28

29

30

31

32 Enhancement of drug stability Enteric coating Complexation Use of metabolism inhibitors

33

Enhancement of gastrointestinal retention 34

35

36
Tags